You have read all your free articles, to continue reading subscribe to read the rest of this content.
Novo Nordisk has opened a new manufacturing facility in the Kaluga region of Russia for the production of modern devices for administering insulin for treating diabetes. The facility will produce both Penfill® cartridges and FlexPen® prefilled insulin injection pens for the Russian market, accordiAlready a subscriber Login You have read…
AstraZeneca’s Saphnelo has been recommended for marketing authorization in the European Union (EU) as an add-on therapy for the treatment of adult patients with moderate to severe, active autoantibody-positive systemic lupus erythematosus (SLE), despite receiving standard therapy. If approved, Already a subscriber Login You have read all your free articles,…
AstraZeneca has entered into a collaboration with Regeneron to research, develop and commercialize small molecule compounds directed against the GPR75 target with the potential to treat obesity and related co-morbidities. The companies will evenly split research and development costs and share eqAlready a subscriber Login You have read all your…
The European Commission has granted an extension of the indication for Fiasp (fast-acting insulin aspart), approving it for the treatment of diabetes in adolescents and children (aged one year and above). This complements the previous indication, which covered adults only. “We are very pleasAlready a subscriber Login You have read…
